Moleculin Biotech Inc. (MBRX)
NASDAQ · Healthcare
Moleculin Biotech Inc. Shareholder Equity 2020–2025
Moleculin Biotech Inc. annual shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Moleculin Biotech Inc. shareholder equity as of December 31, 2025: 15.0M, a 150.98% increase year-over-year.
- Moleculin Biotech Inc. shareholder equity for 2025 were 15.0M, a 150.98% increase from 2024.
- Moleculin Biotech Inc. shareholder equity for 2024 were 6.0M, a 77.07% decrease from 2023.
- Moleculin Biotech Inc. shareholder equity for 2023 were 26.1M, a 50.04% decrease from 2022.
- Moleculin Biotech Inc. shareholder equity for 2022 were 52.2M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Moleculin Biotech Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $15 |
| 2024 | $6 |
| 2023 | $26 |
| 2022 | $52 |
| 2021 | $79 |
| 2020 | $18 |
Moleculin Biotech Inc. Shareholder Equity — FAQ
Moleculin Biotech Inc. (MBRX) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MBRX's shareholder equity history?
The chart and table above show Moleculin Biotech Inc.'s shareholder equity by year and by quarter, including the growth rate.